Biogen
BIIB
BIIB
1,101 hedge funds and large institutions have $45B invested in Biogen in 2019 Q4 according to their latest regulatory filings, with 203 funds opening new positions, 272 increasing their positions, 470 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.67% less ownership
Funds ownership: 86.84% → 84.17% (-2.7%)
30% less call options, than puts
Call options by funds: $1.27B | Put options by funds: $1.82B
42% less repeat investments, than reductions
Existing positions increased: 272 | Existing positions reduced: 470
Holders
1,101
Holding in Top 10
31
Calls
$1.27B
Puts
$1.82B
Top Buyers
| 1 | +$292M | |
| 2 | +$276M | |
| 3 | +$269M | |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
+$192M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$188M |
Top Sellers
| 1 | -$527M | |
| 2 | -$422M | |
| 3 | -$322M | |
| 4 |
D.E. Shaw & Co
New York
|
-$322M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$316M |